Literature DB >> 6259203

Human infective dose determinations for oral poliovirus type 1 vaccine in infants.

T E Minor, C I Allen, A A Tsiatis, D B Nelson, D J D'Alessio.   

Abstract

The 50, 10, and 1% human infective doses of poliovirus type 1 vaccine administered orally to 32 infants were estimated to be 72, 39, and 20 tissue culture infective doses, respectively.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6259203      PMCID： PMC273794          DOI： 10.1128/jcm.13.2.388-389.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Clinical trials in infants of orally administered attenuated poliomyelitis viruses.

Authors:  S A PLOTKIN; H KOPROWSKI; J STOKES
Journal:  Pediatrics       Date:  1959-06       Impact factor: 7.124

2.  Present status of attenuated live-virus poliomyelitis vaccine.

Authors:  A B SABIN
Journal:  J Am Med Assoc       Date:  1956-12-29

3.  Immunization against poliomyelitis with living attenuated virus.

Authors:  H KOPROWSKI
Journal:  Am J Trop Med Hyg       Date:  1956-05       Impact factor: 2.345

4.  Clinical investigations on attenuated strains of poliomyelitis virus; use as a method of immunization of children with living virus.

Authors:  H KOPROWSKI; T W NORTON; G A JERVIS; T L NELSON; D L CHADWICK; D J NELSEN; K F MEYER
Journal:  J Am Med Assoc       Date:  1956-03-17

5.  Living attenuated poliomyelitis virus as an immunizing agent of man.

Authors:  H KOPROWSKI
Journal:  S Afr Med J       Date:  1955-10-29

6.  Counterimmunoelectrophoresis test for immunoglobulin M antibodies to group B coxsackievirus.

Authors:  T E Minor; P B Helstrom; D B Nelson; D J D'Alessio
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

7.  Minimal infective dose of attenuated poliovirus for man.

Authors:  M Katz; S A Plotkin
Journal:  Am J Public Health Nations Health       Date:  1967-10
  7 in total
  8 in total

1.  Elimination of viruses and indicator bacteria at each step of treatment during preparation of drinking water at seven water treatment plants.

Authors:  P Payment; M Trudel; R Plante
Journal:  Appl Environ Microbiol       Date:  1985-06       Impact factor: 4.792

Review 2.  Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus.

Authors:  Julie K Pfeiffer
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

Review 3.  Minimum Infective Dose of the Major Human Respiratory and Enteric Viruses Transmitted Through Food and the Environment.

Authors:  Saber Yezli; Jonathan A Otter
Journal:  Food Environ Virol       Date:  2011-03-16       Impact factor: 2.778

4.  New recognition of Enterovirus infections in bottlenose dolphins (Tursiops truncatus).

Authors:  Hendrik H Nollens; Rebecca Rivera; Gustavo Palacios; James F X Wellehan; Jeremiah T Saliki; Shannon L Caseltine; Cynthia R Smith; Eric D Jensen; Jeffrey Hui; W Ian Lipkin; Pamela K Yochem; Randall S Wells; Judy St Leger; Stephanie Venn-Watson
Journal:  Vet Microbiol       Date:  2009-06-06       Impact factor: 3.293

5.  Survival and detection of rotaviruses on environmental surfaces in day care centers.

Authors:  B H Keswick; L K Pickering; H L DuPont; W E Woodward
Journal:  Appl Environ Microbiol       Date:  1983-10       Impact factor: 4.792

6.  Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.

Authors:  Michael Famulare; Christian Selinger; Kevin A McCarthy; Philip A Eckhoff; Guillaume Chabot-Couture
Journal:  PLoS Biol       Date:  2018-04-27       Impact factor: 8.029

7.  Spread and prevention of some common viral infections in community facilities and domestic homes.

Authors:  J Barker; D Stevens; S F Bloomfield
Journal:  J Appl Microbiol       Date:  2001-07       Impact factor: 3.772

8.  The effect of ongoing exposure dynamics in dose response relationships.

Authors:  Josep M Pujol; Joseph E Eisenberg; Charles N Haas; James S Koopman
Journal:  PLoS Comput Biol       Date:  2009-06-05       Impact factor: 4.475
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.